Seminario web de la AFTD: Diagnóstico de la afasia progresiva primaria
With primary progressive aphasia (PPA), problems with language and communication typically deteriorate gradually over time. Initial symptoms are sometimes attributed to anxiety or stress until the ongoing symptoms become disruptive enough to prompt further assessment by a specialist. This webinar is intended for clinicians to support early detection and accurate diagnosis of PPA. Learners will…
Leer másDígale a sus legisladores: reautoricen la financiación de la Ley para los Estadounidenses de Edad Avanzada
You may think that because frontotemporal degeneration strikes many people in the middle of their life, that the Older Americans Act may not apply to you. But the OAA provides funding for services for adult family members and other adults who care for individuals with Alzheimer’s disease and related disorders in their home, regardless of…
Leer másFomentando la esperanza: la AFTD organiza la mesa redonda de investigación de la FTD de 2024
The FTD Research Roundtable is an annual program designed to accelerate FTD drug development by convening various scientific stakeholders to identify common challenges and advance solutions for FTD clinical trials. Biopharmaceutical companies currently conducting FTD pre-clinical and clinical trials are invited to join the FTD Research Roundtable, and in 2024, we were thrilled to have…
Leer másProtegido: A Conversation with Alector’s Vice President of Clinical Development
No hay extracto porque es una entrada protegida.
Leer másAC Immune y Life Molecular Imaging anuncian la designación de vía rápida de la FDA para el trazador PET Tau
Swiss biopharmaceutical company AC Immune announced in late August that its partner, German biopharmaceutical company Life Molecular Imaging (LMI), received a Fast Track Designation from the US Food and Drug Administration (FDA) for a Tau PET tracer. PET, or positron emission tomography, is a form of medical imaging that uses a radioactive tracer to visualize…
Leer másEmma Heming Willis comparte su experiencia en FTD y su trabajo de defensa en la revista “Town & Country”
Emma Heming Willis spoke with journalist Katie Couric about her journey as an FTD care partner, as well as her advocacy for FTD legislation and research following the diagnosis of her husband, Bruce Willis, in an interview published in the November 2024 issue of “Town & Country.” For her ongoing advocacy work, Mrs. Willis will be…
Leer más2024: esperanzas para la subasta navideña de vinos escoceses y burbon raros de FTD
Michael Stowell, exalumno de la junta directiva de AFTD, organiza la subasta navideña Driving Hope for FTD Rare Burbon and Scotch de 2024, cuyas ganancias beneficiarán la misión de AFTD. Hay dos formas de participar en este evento, ¡para los locales y para los que no lo son! Subasta en línea: desde ahora y hasta el 24 de noviembre, puede ofertar por vinos raros de Buffalo Trace y…
Leer másRecepción en persona en Portland, Oregón
Conozca a la actriz y cineasta Katie Prentiss para conocer más sobre su nuevo proyecto cinematográfico de larga duración, “Wake Up Maggie”. Los anfitriones Allison Lindauer y David Spencer ofrecerán bebidas y aperitivos en esta jornada de puertas abiertas, que se llevará a cabo el 2 de noviembre de 2024, de 4 a 6 p. m. Se recibirán con gusto las donaciones para “Wake up Maggie”.
Leer másProtegido: Empower a Future Free of FTD with a Year-End Gift
No hay extracto porque es una entrada protegida.
Leer másFomentando la esperanza: AFTD asiste a la reunión de investigadores del Consorcio Tau
Members of the AFTD staff, along with several funding partner organizations, gathered with the world’s top scientists studying tauopathies for the 2024 Tau Consortium Investigators Meeting (TCIM) this September in Denver. The Tau Consortium™ is a collaborative research program that is managed and funded by the Rainwater Charitable Foundation (RCF) that fosters collaboration and knowledge-sharing,…
Leer más